News & Press


#EyeGetDilated: Mark Weinzierl

November 6, 2020

Guest blog post by Mark Weinzierl, OM survivor and MRF Board Member: My name is Mark Weinzierl and for the last 14 years I have been a survivor of a rare cancer that affects your eyes called ocular melanoma (OM). Although it is in the melanoma family, …



The MRF Welcomes Susan Vogel

October 30, 2020

In October 2020, the Melanoma Research Foundation welcomed Susan Vogel to the MRF team as Chief Development Officer. Susan was previously the executive director of the Charles Regional Medical Center Foundation, a position she held since 1999, and brin …



Novartis Know Now: Knowing Rose’s BRAF Status Helped Her Find the Best Course of Treatment

October 27, 2020

Meet Rose Manbachi – a melanoma survivor who benefited from knowing her BRAF status early on, changing the course of treatment. Learn more about Rose’s story and why it was important for her to Know Now and get tested for the BRAF gene mutation in her …



#EyeGetDilated: Mark Weinzierl

October 20, 2020

Guest blog post by Mark Weinzierl, OM survivor and MRF Board Member: My name is Mark Weinzierl and for the last 14 years I have been a survivor of a rare cancer that affects your eyes called ocular melanoma (OM). Although it is in the melanoma family, …



Novartis Know Now: Knowing Deborah’s BRAF Status Saved Her Valuable Time

October 7, 2020

Meet Deborah Wassertzug – a melanoma survivor who benefited from knowing her BRAF status early on, changing the course of treatment. Learn more about Deborah’s story and why it was important for her to Know Now and get tested for the BRAF gene mutation …